Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The squid axon voltage-gated potassium channel is a foundational model in neurobiology, famously characterized by Alan Hodgkin and Andrew Huxley in their Nobel Prize-winning work on the action potential [1]. Located in the giant axon of squids such as Loligo pealeii, this channel is a member of the Kv1 (Shaker-related) family and functions as a 'delayed rectifier' (IK) [2]. Its primary biological role is to mediate the efflux of potassium ions following membrane depolarization, which is essential for the rapid repolarization of the action potential and the maintenance of the resting membrane potential [1]. Although it is not a human therapeutic target, its study has provided the fundamental biophysical principles for understanding human voltage-gated potassium channels, such as KCNA1 (Kv1.1), which are critical in various neurological and cardiovascular diseases [2]. The channel is a classic pharmacological target for blockers such as tetraethylammonium (TEA) and 4-aminopyridine (4-AP), which inhibit the channel by occluding the ion-conducting pore [3]. These interactions have been instrumental in mapping the pore structure and gating mechanisms of ion channels across species [2]. [1] Hodgkin and Huxley, Journal of Physiology, 1952; [2] Rosenthal and Gilly, Proceedings of the National Academy of Sciences, 2003; [3] UniProtKB, Q26657.
Pore blockade of the potassium channel, leading to inhibition of potassium efflux and prolongation of the action potential duration.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Squid axon voltage-gated potassium channel (SqKv1.1).